AU657489B2 - Monoclonal antibody treats HIV-AIDS - Google Patents

Monoclonal antibody treats HIV-AIDS

Info

Publication number
AU657489B2
AU657489B2 AU83932/91A AU8393291A AU657489B2 AU 657489 B2 AU657489 B2 AU 657489B2 AU 83932/91 A AU83932/91 A AU 83932/91A AU 8393291 A AU8393291 A AU 8393291A AU 657489 B2 AU657489 B2 AU 657489B2
Authority
AU
Australia
Prior art keywords
monoclonal antibody
cells
infected
hiv
fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU83932/91A
Other languages
English (en)
Other versions
AU8393291A (en
Inventor
Hans Loibner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of AU8393291A publication Critical patent/AU8393291A/en
Application granted granted Critical
Publication of AU657489B2 publication Critical patent/AU657489B2/en
Assigned to NOVARTIS AG reassignment NOVARTIS AG Request to Amend Deed and Register Assignors: SANDOZ LTD.
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
AU83932/91A 1990-08-11 1991-08-08 Monoclonal antibody treats HIV-AIDS Expired AU657489B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4025499 1990-08-11
DE4025499A DE4025499A1 (de) 1990-08-11 1990-08-11 Verwendung der antikoerper br55-2, deren derivate, konjugate und fragmente zur bekaempfung von hiv-infektionen
PCT/EP1991/001510 WO1992003165A1 (en) 1990-08-11 1991-08-08 New use of a monoclonal antibody

Publications (2)

Publication Number Publication Date
AU8393291A AU8393291A (en) 1992-03-17
AU657489B2 true AU657489B2 (en) 1995-03-16

Family

ID=6412074

Family Applications (1)

Application Number Title Priority Date Filing Date
AU83932/91A Expired AU657489B2 (en) 1990-08-11 1991-08-08 Monoclonal antibody treats HIV-AIDS

Country Status (13)

Country Link
EP (1) EP0547079B1 (enExample)
JP (1) JPH06500771A (enExample)
KR (1) KR930701193A (enExample)
AT (1) ATE136469T1 (enExample)
AU (1) AU657489B2 (enExample)
CA (1) CA2088370C (enExample)
DE (2) DE4025499A1 (enExample)
HU (1) HUT64238A (enExample)
IE (1) IE912823A1 (enExample)
PT (1) PT98622A (enExample)
TW (1) TW223019B (enExample)
WO (1) WO1992003165A1 (enExample)
ZA (1) ZA916313B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0528767T3 (da) * 1991-08-21 2000-04-17 Novartis Ag antistofderivater
KR100279317B1 (ko) * 1992-05-22 2001-01-15 더블류. 하링, 지. 보이롤 단일클론항체
ATE249846T1 (de) * 1998-06-29 2003-10-15 Wolfgang Bergter Antivirale und antiretrovirale radioimmunpharmaka auf der basis von alpha- und beta-strahlern

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0304663A1 (en) * 1987-07-31 1989-03-01 Japan Immuno Research Laboratories Co., Ltd. Detection method of abnormally responding lymphocytes as well as detection reagent and kit therefor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI873233A0 (fi) * 1985-11-25 1987-07-23 Cytogen Corp Modifierade virala glykoproteiner.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0304663A1 (en) * 1987-07-31 1989-03-01 Japan Immuno Research Laboratories Co., Ltd. Detection method of abnormally responding lymphocytes as well as detection reagent and kit therefor

Also Published As

Publication number Publication date
CA2088370A1 (en) 1992-02-12
EP0547079B1 (en) 1996-04-10
KR930701193A (ko) 1993-06-11
WO1992003165A1 (en) 1992-03-05
IE912823A1 (en) 1992-02-12
JPH06500771A (ja) 1994-01-27
EP0547079A1 (en) 1993-06-23
CA2088370C (en) 2003-03-25
ZA916313B (en) 1993-04-28
HUT64238A (en) 1993-12-28
DE4025499A1 (de) 1992-02-13
HU9300349D0 (en) 1993-05-28
ATE136469T1 (de) 1996-04-15
DE69118702D1 (de) 1996-05-15
DE69118702T2 (de) 1996-09-05
TW223019B (enExample) 1994-05-01
PT98622A (pt) 1992-06-30
AU8393291A (en) 1992-03-17

Similar Documents

Publication Publication Date Title
CA1319899C (en) Monoclonal antibodies to fc receptors for immunoglobulin g on human mononuclear phagocytes
US6096311A (en) Methods for use of monoclonal antibodies specific for the high affinity Fc receptor for immunoglobulin G
EP0515571B1 (en) Hybrid reagents capable of selectively releasing molecules into cells
US5591829A (en) Antibodies modified with toxic substance
CA2006353A1 (en) Monoclonal antibody to human carcinomas
EP0496818B1 (en) MONOCLONAL ANTIBODY SPECIFIC FOR IgA RECEPTOR
Derocq et al. Comparison of the cytotoxic potency of T101 Fab, F (ab') 2 and whole IgG immunotoxins.
EP0407399A1 (en) Immunosupression with anti-pan t-cell immunotoxin compositions
AU657489B2 (en) Monoclonal antibody treats HIV-AIDS
US5407805A (en) Monoclonal antibody reactive to various human leukemia and lymphoma cells and methods of using same for diagnosis and treatment
JPH05506142A (ja) Ｈｉｖ蛋白質の非免疫支配エピトープに特異的なモノクローナル抗体
US5523085A (en) Monoclonal antibody in destruction of small cell lung carcinoma
AU627468B2 (en) Antibody modified with toxin
EP0827513B1 (en) Reagents for treatment and diagnostic visualisation, particularly in cancer
CA2074512A1 (en) Medicaments and methods for treating acquired immune deficiency syndrome (aids) and aids-related complex (arc) employing anti-carbohydrate antibodies and carbohydrate antigens
IL101475A (en) Monoclonal antibodies that respond with F receptors as the binding is not blocked by human GJI
CA2622018A1 (en) Cellular and serum protein anchors and conjugates